Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2024
10. Dezember 2024 16:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
MADD Canada Launches Project Red Ribbon Awareness Campaign in Newfoundland and Labrador
06. Dezember 2024 06:00 ET
|
MADD Canada
MOUNT PEARL, Newfoundland and Labrador, Dec. 06, 2024 (GLOBE NEWSWIRE) -- MADD Canada is launching its provincial Project Red Ribbon campaign in Newfoundland and Labrador to prevent impaired driving...
Post-Herpetic Neuralgia Treatment Market Projected to Reach $1.38 Billion by 2034, Growing at a CAGR of 5.3% | Fact.MR Report
04. November 2024 07:30 ET
|
FACT.MR
Rockville, MD, Nov. 04, 2024 (GLOBE NEWSWIRE) -- The global post herpetic neuralgia treatment market is calculated to reach a size of US$ 822.4 million in 2024 and climb to US$ 1.38 billion by the...
MADD Canada Holds Memorial Ceremony to Honour Victims of Impaired Driving
03. Oktober 2024 05:30 ET
|
MADD Canada
GRAND FALLS-WINDSOR, Newfoundland and Labrador, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Families and friends of innocent victims of alcohol and drug-related crashes will gather this Saturday to honour...
Names of Four Nova Scotia Victims of Impaired Driving will be Added to the Provincial Monument
11. September 2024 07:00 ET
|
MADD Canada
DARTMOUTH, Nova Scotia, Sept. 11, 2024 (GLOBE NEWSWIRE) -- MADD Canada will hold its annual Memorial Ceremony to pay tribute to those who lost their lives or suffered injuries in crashes involving...
Avid Bioservices to Participate at Upcoming Investor Conferences
07. Mai 2024 16:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
[Latest] Global Cancer Supportive Care Drugs Market Size/Share Worth USD 32,783.2 Billion by 2033 at a 3.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
06. Mai 2024 12:30 ET
|
Custom Market Insights
Austin, TX, USA, May 06, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Cancer Supportive Care Drugs Market Size, Trends and Insights By Drug Type...
Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024
24. April 2024 17:25 ET
|
Avid Bioservices, Inc
-- Recorded Third Quarter Revenue of $33.8 Million -- -- Signed $41 Million in Net New Business Resulting in Record High Backlog of $206 Million -- -- Celebrated Completion of Recent Expansion...
Dyadic Announces Strategic Partnership Agreement to Develop Affordable Rabies Prophylactics and Vaccines Using its Proprietary C1 Cell Microbial Protein Production Platform
28. Februar 2024 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla. and BUNNIK, the Netherlands, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company...
Dyadic to Attend BIO CEO & Investor Conference and European Industry Events
01. Februar 2024 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...